東富龍(300171.SZ):上半年淨利大增350.16%至1.72億元
格隆匯8月19日丨東富龍(300171.SZ)披露2020年半年度報告,報告期內,公司實現營業收入11.89億元,同比增長28.41%;歸屬於上市公司股東的淨利潤1.72億元,同比增長350.16%;歸屬於上市公司股東的扣除非經常性損益後的淨利潤1.36億元,同比增長859.23%;基本每股收0.2739元。
報告期內,國內外疫情全面爆發,公司積極保障與推動預設的國內項目交付計劃,時刻關注國際項目進展情況,通過線上方式與客户保持有效的溝通,快速響應客户需求。公司持續貫徹精準管理理念,推行數字化變革,材料成本、費用佔營業收入的比重較上年同期均有所下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.